These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 21854278)

  • 1. Assessing drug use during follow-up: direct comparison of candidate outcome definitions in pooled analyses of addiction treatment studies.
    Korte JE; Magruder KM; Chiuzan CC; Logan SL; Killeen T; Bandyopadhyay D; Brady KT
    Am J Drug Alcohol Abuse; 2011 Sep; 37(5):358-66. PubMed ID: 21854278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Power of automated algorithms for combining time-line follow-back and urine drug screening test results in stimulant-abuse clinical trials.
    Oden NL; VanVeldhuisen PC; Wakim PG; Trivedi MH; Somoza E; Lewis D
    Am J Drug Alcohol Abuse; 2011 Sep; 37(5):350-7. PubMed ID: 21854277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Empirically contrasting urine drug screening-based opioid use disorder treatment outcome definitions.
    Brandt L; Odom GJ; Hu MC; Castro C; Balise RR;
    Addiction; 2024 Jul; 119(7):1289-1300. PubMed ID: 38616571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender research in the National Institute on Drug Abuse National Treatment Clinical Trials Network: a summary of findings.
    Greenfield SF; Rosa C; Putnins SI; Green CA; Brooks AJ; Calsyn DA; Cohen LR; Erickson S; Gordon SM; Haynes L; Killeen T; Miele G; Tross S; Winhusen T
    Am J Drug Alcohol Abuse; 2011 Sep; 37(5):301-12. PubMed ID: 21854272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-report and urine drug screen concordance among women with co-occurring PTSD and substance use disorders participating in a clinical trial: Impact of drug type and participant characteristics.
    Ruglass LM; Shevorykin A; Zhao Y; Killeen TK; Bauer AG; Morgan-López AA; Back SE; Fitzpatrick S; López-Castro T; Norman SB; Saavedra LM; Hien DA
    Drug Alcohol Depend; 2023 Mar; 244():109769. PubMed ID: 36696843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does urine drug abuse screening help for managing patients? A systematic review.
    Dupouy J; Mémier V; Catala H; Lavit M; Oustric S; Lapeyre-Mestre M
    Drug Alcohol Depend; 2014 Mar; 136():11-20. PubMed ID: 24417964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NIDA's Clinical Trials Network: an opportunity for HIV research in community substance abuse treatment programs.
    Tross S; Campbell AN; Calsyn DA; Metsch LR; Sorensen JL; Shoptaw S; Haynes L; Woody GE; Malow RM; Brown LS; Feaster DJ; Booth RE; Mandler RN; Masson C; Holmes BW; Colfax G; Brooks AJ; Hien DA; Schackman BR; Korthuis PT; Miele GM;
    Am J Drug Alcohol Abuse; 2011 Sep; 37(5):283-93. PubMed ID: 21854270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determining the primary endpoint for a stimulant abuse trial: lessons learned from STRIDE (CTN 0037).
    Trivedi MH; Greer TL; Potter JS; Grannemann BD; Nunes EV; Rethorst C; Warden D; Ring KM; Somoza E
    Am J Drug Alcohol Abuse; 2011 Sep; 37(5):339-49. PubMed ID: 21854276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using a latent variable approach to inform gender and racial/ethnic differences in cocaine dependence: a National Drug Abuse Treatment Clinical Trials Network study.
    Wu LT; Pan JJ; Blazer DG; Tai B; Stitzer ML; Woody GE
    J Subst Abuse Treat; 2010 Jun; 38 Suppl 1():S70-9. PubMed ID: 20307798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ten take home lessons from the first 10 years of the CTN and 10 recommendations for the future.
    Carroll KM; Ball SA; Jackson R; Martino S; Petry NM; Stitzer ML; Wells EA; Weiss RD
    Am J Drug Alcohol Abuse; 2011 Sep; 37(5):275-82. PubMed ID: 21854269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of study design to recruitment and retention in CTN trials.
    Wakim PG; Rosa C; Kothari P; Michel ME
    Am J Drug Alcohol Abuse; 2011 Sep; 37(5):426-33. PubMed ID: 21854286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing ethnic minority participation in substance abuse clinical trials: lessons learned in the National Institute on Drug Abuse's Clinical Trials Network.
    Burlew K; Larios S; Suarez-Morales L; Holmes B; Venner K; Chavez R
    Cultur Divers Ethnic Minor Psychol; 2011 Oct; 17(4):345-56. PubMed ID: 21988575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary outcome indices in illicit drug dependence treatment research: systematic approach to selection and measurement of drug use end-points in clinical trials.
    Donovan DM; Bigelow GE; Brigham GS; Carroll KM; Cohen AJ; Gardin JG; Hamilton JA; Huestis MA; Hughes JR; Lindblad R; Marlatt GA; Preston KL; Selzer JA; Somoza EC; Wakim PG; Wells EA
    Addiction; 2012 Apr; 107(4):694-708. PubMed ID: 21781202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conducting research with racial/ethnic minorities: methodological lessons from the NIDA Clinical Trials Network.
    Burlew AK; Weekes JC; Montgomery L; Feaster DJ; Robbins MS; Rosa CL; Ruglass LM; Venner KL; Wu LT
    Am J Drug Alcohol Abuse; 2011 Sep; 37(5):324-32. PubMed ID: 21854274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study results from the Clinical Trials Network's first 10 years: where do they lead?
    Wells EA; Saxon AJ; Calsyn DA; Jackson TR; Donovan DM
    J Subst Abuse Treat; 2010 Jun; 38 Suppl 1(Suppl 1):S14-30. PubMed ID: 20307792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Site selection in community-based clinical trials for substance use disorders: strategies for effective site selection.
    Potter JS; Donovan DM; Weiss RD; Gardin J; Lindblad R; Wakim P; Dodd D
    Am J Drug Alcohol Abuse; 2011 Sep; 37(5):400-7. PubMed ID: 21854283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retention of under-represented minorities in drug abuse treatment studies.
    Magruder KM; Bichun Ouyang ; Miller S; Tilley BC
    Clin Trials; 2009 Jun; 6(3):252-60. PubMed ID: 19528134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urine drug screen findings among ambulatory oncology patients in a supportive care clinic.
    Rauenzahn S; Sima A; Cassel B; Noreika D; Gomez TH; Ryan L; Wolf CE; Legakis L; Del Fabbro E
    Support Care Cancer; 2017 Jun; 25(6):1859-1864. PubMed ID: 28120116
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.